Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Salva

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Revista Clinica Espanola|April 1, 1990
[Determination of antibodies against Borrelia burgdorferi in patients with morphea, lichen sclerosus et atrophicus and erythema chronicum migrans]I Pinazo Canales, I Betlloch Mas, F Mestre Bauza, et al.
Anales Espanoles De Pediatria|January 1, 1989
[Childhood shigellosis: clinical and microbiological characteristics]J Reina Prieto, F Salva Armengod, C Morales Oses, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases-the PURPLE trialS Kasper, E Elez, U Neumann, et al.
ESMO Open|May 1, 2026
Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitorsJ Ros, M C de Grandis, V Navarro, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Revista Clinica Espanola|April 1, 1990
[Determination of antibodies against Borrelia burgdorferi in patients with morphea, lichen sclerosus et atrophicus and erythema chronicum migrans]I Pinazo Canales, I Betlloch Mas, F Mestre Bauza, et al.
Anales Espanoles De Pediatria|January 1, 1989
[Childhood shigellosis: clinical and microbiological characteristics]J Reina Prieto, F Salva Armengod, C Morales Oses, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases-the PURPLE trialS Kasper, E Elez, U Neumann, et al.
ESMO Open|May 1, 2026
Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitorsJ Ros, M C de Grandis, V Navarro, et al.
Pageof 2